Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
HEALWELL AI ( (TSE:AIDX) ) has issued an announcement.
HEALWELL AI’s subsidiary, Intrahealth Systems Limited, has been selected by Public Health Sudbury & Districts to implement its Profile EMR platform. This initiative aims to modernize digital infrastructure, improve efficiency, and enhance public health services across various programs, including infectious disease control, sexual health, and environmental health. The deployment of Profile is expected to strengthen community health outcomes by enabling data-driven decision-making and increasing accessibility through digital portals and telemedicine.
The most recent analyst rating on (TSE:AIDX) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on HEALWELL AI stock, see the TSE:AIDX Stock Forecast page.
Spark’s Take on TSE:AIDX Stock
According to Spark, TipRanks’ AI Analyst, TSE:AIDX is a Neutral.
HEALWELL AI’s overall score is primarily impacted by its strong revenue growth overshadowed by significant profitability and cash flow issues. The technical analysis indicates a bearish trend, and the valuation is unattractive due to negative earnings and lack of dividends.
To see Spark’s full report on TSE:AIDX stock, click here.
More about HEALWELL AI
HEALWELL AI Inc. is a healthcare artificial intelligence company focused on preventative care. It operates through its subsidiary, Intrahealth Systems Limited, which provides enterprise-grade electronic medical record (EMR) platforms. The company is committed to enhancing healthcare delivery through advanced digital tools and data-driven solutions.
Average Trading Volume: 322,669
Technical Sentiment Signal: Sell
Current Market Cap: C$395.5M
For detailed information about AIDX stock, go to TipRanks’ Stock Analysis page.

